Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
27 hedge funds and large institutions have $51.7M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 9 closing their positions.
23% more capital invested
Capital invested by funds: $42M → $51.7M (+$9.74M)
16% less funds holding
Funds holding: 32 → 27 (-5)
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
51% less call options, than puts
Call options by funds: $261K | Put options by funds: $530K
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$6.72M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$3.3M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$1.01M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$256K |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$134K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.56M |
| 2 |
ACM
Alistair Capital Management
Dallas,
Texas
|
-$1.7M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.33M |
| 4 |
Renaissance Technologies
New York
|
-$431K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$209K |
CORV Hedge Fund Activity: Q3 2014 in Review
27 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q3 2014, worth a combined $51.7M — up 23% from $42M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CORV and 4 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 6 added.
The largest buyer was Putnam Investments, opening a new position worth an estimated $6.72M. The largest seller was Fidelity Investments, cutting an estimated $3.56M.
- 27 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q3 2014, down from 32 in Q2 2014.
- Funds reported $51.7M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q3 2014, up 23% quarter-over-quarter.
- 4 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q3 2014 and 9 closed out, a net change of -5 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q3 2014 was Putnam Investments, an estimated $6.72M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q3 2014 was Fidelity Investments, an estimated $3.56M sold.
Based on aggregated 13F filings for Q3 2014.